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1Around two-thirds of stroke, survivors leave hospital with disability. Some make a full recovery while for others 
stroke is a long-term condition. Over 1.2 million stroke survi-
vors live in the United Kingdom where stroke is the common-
est cause of complex disability.1
Stroke units and early supported discharge (ESD) serv-
ices have been shown to be clinically effective and cost-ef-
fective.2,3 However, there is limited evidence to guide 
rehabilitation to optimize recovery and meet the longer term 
needs of stroke survivors. Lack of evidence of effectiveness 
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has meant that provision of longer term stroke care remains 
a low priority for those who are responsible for funding the 
development of new services and as a result service devel-
opment has lagged behind developments for acute care and 
early rehabilitation. Provision of longer term services beyond 
ESD are limited and vary across the United Kingdom,4,5 and 
many stroke survivors feel marginalized in the longer term 
by health and social services.6 This study evaluated a new 
longer term community stroke rehabilitation service which 
commenced when routine ESD ended.
Methods
Study Design
The methods of the extended stroke rehabilitation service (EXTRAS) 
trial have been reported previously.7 The study was a parallel-group 
observer-blind multicenter individually randomized controlled trial 
which took place in 19 UK National Health Service (NHS) study 
centers. All study centers had an ESD service comprising a multidis-
ciplinary stroke team which provided rehabilitation in the commu-
nity, commencing within 48 hours of discharge from hospital. Ethical 
approval was granted by the National Research Ethics Committee.
We will make anonymized data from this research project avail-
able to the scientific community with as few restrictions as fea-
sible, while retaining exclusive use until the publication of major 
outputs. Those interested in accessing data should contact the cor-
responding author.
Participants
Adults with a new stroke (first-ever or recurrent) were eligible to 
take part if they received ESD and were able to participate in a re-
habilitation program focussing on extended activities of daily liv-
ing. Participants provided written consent. Aphasia friendly study 
materials were available for patients with communication difficul-
ties. Patients lacking capacity to consent could be included if a 
consultee agreed to their enrollment and was prepared to assist 
with study processes.
Randomization and Blinding
Randomization to a study group took place at discharge from rou-
tine ESD using an online web-based service. Stratification by study 
center was used, and permuted block sequences assigned participants 
to intervention or control in a 1:1 ratio. Due to the nature of the inter-
vention, patients, carers, and staff providing EXTRAS could not be 
blinded to study group. However, outcome data were intended to be 
collected by a blinded researcher, and any unblinding was recorded.
Intervention
The extended stroke rehabilitation service sought to help individu-
als to maximize their recovery and adjust to their residual disability 
in the context of their day to day activities. A senior member of the 
ESD team provided 5 structured reviews at 1, 3, 6, 12, and 18 months 
post-ESD. Most reviews were intended to be conducted by telephone 
and covered issues identified in a national survey of patient needs8 
and other literature: mobility; personal care; mealtimes; domestic 
activities; work and volunteering; hobbies and interests; driving and 
transport; communication; memory and concentration; mood, anxiety 
and depression; medical issues; pain; and other issues. The patient’s 
progress was reviewed, along with their current rehabilitation needs 
and service provision. Agreed rehabilitation goals were set, and an 
action plan was made at each review. The action plan could include 
verbal advice and encouragement; discussion with services currently 
involved in the patient’s care; signposting to local activities, commu-
nity services or voluntary services; referral to stroke services, reha-
bilitation services or primary care. The reviews were multifaceted, 
reflecting current clinical practice, and included self-management 
and feedback. EXTRAS was provided in addition to usual NHS care. 
The number of interviews and their intervals was a pragmatic decision 
based on what would be achievable and affordable within the NHS. A 
detailed description of EXTRAS using the Template for Intervention 
Description and Replication checklist9 is provided in Table I in the 
online-only Data Supplement.
Control
Patients randomized to the control group received usual NHS care. 
After completion of routine ESD, patients who had ongoing reha-
bilitation needs could be referred to a range of services (eg, neurore-
habilitation teams; day hospital; community rehabilitation services) 
depending on local availability.
Data Collection and Outcome Measures
Before randomization, baseline data collection included: demog-
raphy; stroke type and subtype; performance in extended activities 
of daily living (Nottingham Extended Activities of Daily Living 
[NEADL] Scale)10; health status (Oxford Handicap Scale [OHS])11; 
mood (Hospital Anxiety and Depression [HAD] Scale)12; quality of 
life (EQ-5D-5L)13; and prestroke resource usage (adaption of Client 
Service Receipt Inventory ).14
Outcome data were collected by telephone at 12 and 24 months 
post-randomization by a researcher based in the study co-ordinating 
center. Where a telephone interview was not possible, a postal ques-
tionnaire or a face to face assessment was undertaken.
The primary outcome was performance in extended activities 
of daily living measured by the NEADL Scale10 at 24 months post-
randomization. Secondary outcomes were health status (OHS),11 
mood (HAD Scale),12 and experience of services (survey based on 
Picker Institute questions)15 at 12 and 24 months post-randomization. 
Quality-adjusted life-years (QALYs) were derived from responses to 
the EQ-5D-5L13 and an England population tariff.16 Resource utiliza-
tion data (adaption of Client Service Receipt Inventory)14 were used 
to generate an average cost per participant. Questions to capture ad-
verse events were included in study outcome proformas.
Statistical Methods
To provide 90% power to detect a clinically important difference of 
6 points on the NEADL Scale10 (scored 0–66, SD 18), follow-up data 
from 382 patients split equally between intervention, and control 
groups were required. Based on other stroke rehabilitation studies, 
it was estimated that there could be up to 25% attrition between ran-
domization and 24 months. To allow for this, 510 patients were re-
quired to be randomized into the study.
Analyses were performed on an intention to treat basis. Where 
no more than 20% of questions were missing data on specific scales, 
simple imputation was used to replace missing items.17 Mean scores 
on the NEADL Scale were compared between intervention and con-
trol groups using multiple linear regression, including terms for 
center, baseline OHS, age and sex. In terms of secondary outcomes, 
ordinal regression was used to analyze the OHS, and multiple linear 
regression was used to analyze the 2 separate domains of the HAD 
Scale, all analyses were adjusted for the same covariates as above. 
The responses to the individual experience of service questions 
were dichotomized to create proportions of patients “in agreement” 
or “satisfied,” and the difference in proportions between groups re-
ported with a 95% CI. In addition, a post hoc analysis of the HAD 
Scale considered those patients scoring 8 or more to be cases of anx-
iety or depression as this is how the HAD Scale is used in clinical 
practice,12 and logistic regression was used to compare the random-
ization groups on this binary variable at 12 and 24 months. Odds 
ratios with 95% CI were reported for an unadjusted model, and one 
adjusted for the covariates listed above.
Cost-effectiveness was estimated from a health and social care 
providers’ perspective over the trial period. Unit costs for resources 
used were obtained from routine sources, for example, Personal Social 
Services Research Unit and NHS Reference costs.18 For EXTRAS, 
each review was estimated to require 2 hours of staff time, costed at 
D
ow
nloaded from
 http://ahajournals.org by on October 29, 2019
Rodgers et al  Extended Stroke Rehabilitation Service Trial  3
£44 ($64) per hour. Costs in the second year were discounted (3.5%) 
giving a total EXTRAS cost of £437 ($632) per patient. Differences 
in costs were estimated using a general linear model with a gamma 
distribution adjusting for center, baseline costs, age and sex. In terms 
of QALYs, linear regression was used to compare intervention and 
control groups adjusting for center, baseline utility, age and sex. A 
cost-effectiveness plane was constructed using QALY data.
Results
Between January 09, 2013 and October 26, 2015, 573 patients 
were randomized (intervention group n=285, control group 
n=288). Retention and follow-up are shown in Figure 1. At 
24 months, outcome data were available for 450/573 (78.5%) 
patients. Fifty-five (9.6%) participants died within the study 
period, and 29 (5.1%) withdrew from the study.
Baseline demography and stroke characteristics are shown 
in Table 1. The randomization groups were well matched. The 
median time between stroke and randomization was 72 days.
Adherence to delivery of the EXTRAS reviews was high: 
1155/1338 (86%) of expected reviews were completed with 
914/1155 (79%) being undertaken by telephone. A physi-
otherapist conducted 56% of reviews. Other professionals 
involved were occupational therapists (28%), nurses (8%), 
speech and language therapists (5%), stroke co-ordinators 
(1%), and dieticians (1%). Of the 258 patients who received at 
least 2 reviews, 167 (65%) had all of their reviews conducted 
by the same reviewer. Full details of the content of EXTRAS 
reviews will be reported elsewhere.
The mean NEADL Scale scores at prestroke, baseline, 12 
and 24 months are shown in Table 2. Patients reported that 
they undertook most activities before their stroke, but the 
mean scores at baseline decreased to 39.8 (SD 16.1) in the 
intervention group and 39.1 (SD 16.1) in the control group. 
Thereafter, the mean scores remained very similar over time 
for those patients remaining in the intervention group and 
decreased very slightly in the control group. The adjusted dif-
ference in means at 24 months (primary outcome analysis) 
was 1.8 (95% CI, −0.7 to 4.2). As the minimum clinically im-
portant difference on the NEADL Scale is 6, the results were 
not consistent with a meaningful change on this scale.
Figure 2 shows the distribution of OHS scores at 12 and 
24 months. At 24 months, the odds of the intervention group Figure 1. Trial profile.
Table 1. Demography and Stroke Characteristics
Intervention Control
Sex, n (%) n=285 n=288
  Male 174 (61.1) 168 (58.3)
  Female 111 (39.0) 120 (41.7)
Age n=285 n=288
  Median [IQR] 71 [60–77] 71 [62–79]
Stroke type, n (%) n=285 n=288
  Cerebral infarct 250 (87.7) 253 (87.9)
  Intracerebral hemorrhage 30 (10.5) 29 (10.1)
  Subarachnoid hemorrhage 5 (1.8) 5 (1.8)
  Unknown 0 1 (0.4)
Stroke subtype, n (%) n=284 n=286
  TACS* 55 (19.4) 60 (21.0)
  PACS† 125 (44.0) 133 (46.5)
  LACS‡ 56 (19.7) 44 (15.4)
  POCS§ 47 (16.6) 49 (17.1)
  Uncertain 1 (0.4) 0
First ever stroke, n% n=285 n=288
  Yes 235 (82.5) 227 (78.8)
Duration of hospital stay, d n=282 n=286
  Median [IQR] 13.5 [6–33] 14 [6–35]
Duration of ESD, d n=283 n=285
  Median [IQR] 43 [36–68] 43 [31–68]
Time (days) from stroke to randomization n=284 n=288
  Median [IQR] 73 [48–111.5] 70 [48–106.5]
Baseline Oxford Handicap Scale, n (%) n=283 n=285
  No symptoms (0) 9 (3.2) 8 (2.8)
  Few symptoms (1) 42 (14.8) 43 (15.1)
  Symptoms caused some change (2) 104 (36.8) 95 (33.3)
  Symptoms significant change (3) 100 (35.3) 99 (34.7)
  Severe symptoms (4) 18 (6.4) 34 (11.9)
  Major symptoms (5) 10 (3.5) 6 (2.1)
ESD indicates early supported discharge; and IQR, interquartile range.
*Total anterior circulation stroke.
†Partial anterior circulation stroke.
‡Lacunar stroke.
§Posterior circulation stroke.
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being in worse health was 0.7× as high than for control patients 
(95% CI, 0.5 to 1.0). The comparison at 12 months was similar.
The mean anxiety and depression HAD Scale scores 
were lower for those in the intervention group at 12 and 24 
months, but the 95% CI for the difference in scores included 
zero. However, the post hoc caseness analysis found that in 
the intervention group, there were significantly fewer cases of 
depression at 12 months (29% intervention group versus 40% 
control group) and significantly fewer cases of anxiety at 24 
months (28% intervention group versus 38% control group; 
Table 2).
For 4of the 19 aspects of care examined in the experience 
of services survey at 24 months, the 95% CI for the differ-
ences in percentage “in agreement” or “satisfied” between the 
groups did not cover the value zero. These were “staff treated 
you with dignity and respect,” “staff met your needs,” “overall 
satisfaction,” and “help with mobility.” These data indicate 
that patients in the intervention group appeared to be more 
satisfied with these aspects of care (Table II in the online-only 
Data Supplement).
Differences in EQ-5D-5L utilities, QALYs and costs 
are shown in Table 3. UK Sterling (£) were converted to 
US Dollars ($) using the purchasing power parities rates 
for 2017 (£1=USD 1.447).19 Patients in the intervention 
group experienced 0.07 (95% CI, 0.01 to 0.12) additional 
QALYs. The mean cost of resource utilization was lower 
in the intervention group: −£311 (−$450 [95% CI, −£3292 
to £2787; −$4764 to $4033). Cost savings were predomi-
nantly in social care rather than health care. Figure 3 shows 
the cost-effectiveness plane and demonstrates that there is 
a 68% chance that EXTRAS is cost saving. At the current 
NHS standard of willingness to pay £20 000 ($28 940) per 
QALY, there was a 90% probability that the EXTRAS inter-
vention is cost-effective.
No association was found between the effectiveness of the 
intervention and prestroke OHS score, baseline NEADL Scale 
score and time in organized stroke care (defined as time as an 
inpatient and time in ESD) which were prespecified explora-
tory analyses (Figures IA through IC in the online-only Data 
Supplement).
Table 2. Comparison of Performance in Nottingham Extended Activities of Daily Living (NEADL Scale) and Mood (HAD Scale)
Nottingham Extended Activities of Daily Living Scale Scores
 
Intervention Control Difference in Means (I–C; 95% CI)
n Mean (SD) n Mean (SD) Unadjusted
Adjusted for Center, 
Baseline OHS, Age and Sex
Prestroke 285 61.0 (8.6) 288 59.7 (10.6) n/a n/a
Baseline 281 39.8 (16.1) 282 39.1 (16.1) n/a n/a
12 mo 239 40.6 (17.7) 247 38.3 (17.0) 2.3 (−0.5 to 5.2) 1.5 (−0.8 to 3.7)
24 mo 219 40.0 (18.1) 231 37.2 (18.5) 2.8 (−0.6 to 6.2) 1.8 (−0.7 to 4.2)
Hospital Anxiety and Depression Scale Scores
 Intervention Control Difference in Means (I–C; 95% CI)
n Mean (SD) n Mean (SD) Unadjusted Adjusted for Center, 
Baseline OHS, Age and Sex
Anxiety baseline 282 5.7 (4.2) 285 5.6 (3.9) n/a n/a
Anxiety 12 mo 238 5.8 (4.3) 246 6.5 (4.7) −0.7 (−1.5 to 0.0) −0.7 (−1.3 to 0.0)
Anxiety 24 mo 217 5.5 (4.3) 230 6.4 (4.6) −0.9 (−1.8 to 0.0) −0.6 (−1.4 to 0.1)
Depression baseline 282 5.4 (3.8) 285 5.4 (3.7) n/a n/a
Depression 12 mo 239 5.7 (4.3) 247 6.5 (4.2) −0.8 (−1.6 to 0.0) −0.7 (−1.5 to 0.0)
Depression 24 moo 217 5.9 (4.3) 230 6.7 (4.6) −0.8 (−1.5 to −0.1) −0.7 (−1.4 to 0.0)
Hospital Anxiety and Depression Scale Caseness Category
 Intervention Control Odds Ratio (I/C; 95% CI)
n Case% n Case% Unadjusted Adjusted for center, OHS, 
Age and Sex
Anxiety baseline 282 28 285 29 n/a n/a
Anxiety 12 mo 238 34 246 39 0.79 (0.55 to 1.15) 0.83 (0.55 to 1.25)
Anxiety 24 mo 217 28 230 38 0.62 (0.41 to 0.92) 0.64 (0.41 to 0.99)
Depression baseline 282 24 285 26 n/a n/a
Depression 12 mo 239 29 247 40 0.61 (0.42 to 0.89) 0.59 (0.39 to 0.90)
Depression 24 mo 217 34 230 39 0.80 (0.55 to 1.18) 0.81 (0.52 to 1.24)
HAD indicates Hospital Anxiety and Depression; and OHS, Oxford Handicap Scale.
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At 12 months, telephone or face to face outcome assess-
ments were conducted for 212 patients in the intervention 
group and 204 in the control group. The remainder were 
undertaken by post. The outcome assessor reported that 
they were unmasked for 37/212 (17.4%) intervention group 
participants and 7/204 (3.4%) in the control group. At 24 
months, these figures were 17/195 (8.7%) and 2/186 (1.1%) 
respectively.
Serious adverse events were reported for 125/285 
(43.9%) patients in the intervention group (total 250 
events) and 130/288 (45.1%) patients in the control group 
(total 254 events). There were no significant differences in 
number of events per patient between the randomization 
groups.
Discussion
The extended stroke rehabilitation service (EXTRAS) did 
not improve stroke patients’ performance in extended activi-
ties of daily living when compared with usual care. However, 
there were fewer cases of anxiety and depression in the in-
tervention group, and patients in the intervention group were 
more satisfied with some aspects of their care. Although there 
is no evidence of a treatment effect on the primary outcome, 
the cost-effectiveness analyses are consistent with EXTRAS 
Figure 2. Distribution of Oxford Handicap Scale (OHS) scores. A, At 12 mo. B, At 24 mo.
Table 3. Costs, EQ-5D-5L Utilities, and QALYs
Intervention Mean (95% CI) n=235 Control Mean (95% CI) n=259
Adjusted Difference* EXTRAS Minus 
Usual Care Mean (95% CI)
Costs
  Health care £5667 (3175 to 8711) £5943 (4839 to 6495) £963 (−160 to 2087)
$8200 (4594 to 12 605) $8600 (7002 to 9398) $1394 (−232 to 3020)
  Social care £7708 (5998 to 11 077) £9656 (7797 to 11 514) −£1788 (−4381 to 806)
$11 154 (8679 to 16 028) $13 972 (11 282 to 16 661) −$2587 (−6339 to 1166)
  Intervention £437 … £437
$632  $632
   Total £13 375 (11 381 to 15 369) £15 599 (12 018 to 19 180) −£311 (−3392 to 2787)†
$19 354 (16 468 to 22 239) $22 572 (17 390 to 27 754) −$450 (−4908 to 4031)
EQ-5D-5L
  Baseline 0.60 (0.56 to 0.63) 0.60 (0.55 to 0.62) 0.01 (NA)
   Utility year 1 0.58 (0.54 to 0.62) 0.52 (0.48 to 0.56) 0.05 (0.00 to 0.09)
   Utility year 2 0.53 (0.49 to 0.58) 0.48 (0.44 to 0.53) 0.04 (0.01 to 0.07)
   Total as QALY 1.12 (1.06 to 1.19) 1.04 (0.98 to 1.10) 0.07 (0.01 to 0.12)
Mean net benefit at £20 000 ($28 940) willingness to pay for QALY £1711 ($2476)
Mean cost-effectiveness ratio
On average EXTRAS dominates usual care
Probability of being cost-effective at £20 000 ($25 600) willingness to pay per QALY 90%
Probability that EXTRAS is cost saving 68%
EXTRAS indicates extended stroke rehabilitation service; and QALY, quality-adjusted life-years.
*Age, sex, baseline utility/costs, standard errors clustered by site.
†Totals subject to estimation differences.
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being associated with cost saving and health-related quality of 
life gain. One explanation of this finding is that the EQ-5D-5L 
captured wider impacts of EXTRAS than the NEADL 
Scale. The Nottingham EADL scale measures performance 
in extended activities of daily living, for example, mobility, 
household chores. The EQ-5D-5L is broader covering: mo-
bility, self-care, usual activities, pain/discomfort, and anxiety/
depression.
Divergent results for primary outcome and health eco-
nomic analyses have been reported in other settings,20 but we 
are not aware of any stroke rehabilitation trials which have 
reported this combination of findings. In clinical trials, the pri-
mary outcome is chosen as it is believed to be the outcome of 
greatest importance. Our intervention sought to improve per-
formance in activities of daily living, and it did not. Secondary 
outcomes are used to evaluate additional effects of an inter-
vention which may be related to the primary question or other 
hypotheses. These effects are also important, but secondary 
outcome results in the context of a neutral primary outcome 
are generally regarded as hypothesis-generating rather than 
hypothesis testing. Nevertheless, our findings suggest that the 
intervention may have improved health-related quality of life, 
mood, and aspects of satisfaction with services. In hindsight, 
performance in extended activities of daily living may not have 
been the best primary outcome measure for the EXTRAS trial 
as this was only one component of recovery after stroke which 
the intervention sought to improve. A more global measure of 
health-related quality of life or societal participation would 
have been a good alternative.
EXTRAS reviews offered stroke survivors regular pre-
planned contact with a stroke specialist, who was part of a 
multidisciplinary team, who knew about their stroke journey. 
Although this trial was undertaken in the United Kingdom, 
the EXTRAS intervention could be used in any healthcare 
setting which provides ESD. Stroke survivors had the oppor-
tunity to discuss their achievements and concerns and to set 
goals and agree action points for ongoing issues. The reviewer 
supported them to reflect on their situation and to be realistic 
about their progress and expectations as well as to become 
more knowledgeable about stroke and the help which was and 
was not available. Self-management was an important part of 
the intervention as we sought to improve the stroke survivor’s 
knowledge, skills, and confidence to manage their condition. 
It is, therefore, perhaps, not surprising that benefits were seen 
in terms of wellbeing, mood and satisfaction with services 
rather than physical activities.
A number of studies have identified that stroke survivors 
have a wide range of longer term physical, psychological, and 
social needs.4,6,8 Trials which evaluated interventions seeking 
to address either single or multiple needs have used a range 
of approaches and outcomes, and are of variable quality. 
Individual community-based rehabilitation studies and subse-
quent meta-analyses have been largely neutral across a range of 
interventions and outcomes. Few studies included a health ec-
onomic evaluation, and QALYs have rarely been reported.21,22
When designing the EXTRAS trial in 2010, we were 
encouraged by the results of a 2003 Cochrane review (14 trials, 
1617 participants) which reported that therapy-based services 
(excluding ESD services) provided to patients with stroke soon 
after discharge from hospital reduced the odds of a poor out-
come (OR, 0.72 [95% CI, 0.57 to 0.92]) and increased perfor-
mance in personal activities of daily living compared to usual 
care.23 However, a 2008 Cochrane review (5 trials, 487 partici-
pants) found inconclusive evidence that similar interventions 
provided one year or more after stroke were effective.24
Our intervention went beyond trying to improve per-
formance in extended activities of daily living as we sought 
to address the full range of long-term needs experienced by 
stroke survivors, and therefore EXTRAS has some similarities 
to the interventions provided by stroke liaison workers who 
are healthcare workers or volunteers who provide education, 
social support, and liaison with services. A 2010 Cochrane re-
view (16 studies, 4759 participants) found no benefit in terms 
of perceived health, mood, activities or participation.25 As with 
EXTRAS, intervention participants were more satisfied with 
some aspects of service provision. Patients with mild to mod-
erate disability (Barthel ADL score 15-19) who were supported 
by a stroke liaison worker were reported to have reduced death 
and disability (odds ratio, 0.62 [95% CI, 0.44 to 0.87]).
The LoTS (Longer Term Stroke) Care trial was published 
after the start of the EXTRAS trial.21 This large cluster RCT 
evaluated a system of care where stroke coordinators, who 
were community-based health care professionals with experi-
ence in stroke care, were trained to follow a structured assess-
ment and treatment action plan working with patients and 
carers after hospital discharge. No improvement in outcomes 
was seen for patients or carers in the intervention group com-
pared with usual care and health, and social care costs were 
similar between both randomization groups.
Self-management interventions seek to encourage people 
with chronic conditions to take an active part in their own 
care, and this was one of the components of EXTRAS. 
Approaches to self -management include: problem-solving; 
goal setting; decision making; self-monitoring; and coping 
with the condition. Self-management programmes seek to im-
prove self-efficacy which is “the belief we have in our own 
abilities, specifically our ability to meet the challenges ahead 
of us, and complete a task successfully.”26 A 2016 Cochrane 
review of self-management programmes for people with 
Figure 3. Cost-effectiveness plane. QALYs indicates quality-adjusted 
life-years.
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stroke (14 studies, 1863 participants) reported that these pro-
grams improved quality of life (standardized mean difference 
random effects, 0.34 [95% CI, 0.05 to 0.62]) and improved 
self-efficacy (standardized mean difference random effects, 
0.33 [95% CI, 0.04 to 0.61]), but they had no impact on activ-
ities of daily living or mood.27
The EXTRAS trial is one of the largest randomized con-
trolled trials of a new community stroke service undertaken to 
date. All participants received stroke unit and ESD care before 
participating in the trial, in accordance with best practice. One 
of the strengths of the study is the completeness and quality of 
the data. Follow-up levels were high at all assessment points 
with low levels of missing data.
One potential criticism is that reviews were primarily 
undertaken by telephone. Telephone reviews were selected 
not only because they were more affordable, but also because 
they were likely to be less disruptive to a participant’s daily 
routine than a clinic visit. We did not use video or more so-
phisticated technology, as many participants would have not 
had access or experience in using them. As EXTRAS reviews 
were undertaken by telephone; we felt that it was important 
that they were undertaken by a stroke specialist with experi-
ence in community rehabilitation who knew the patient, who 
had expertise in goal setting, and detailed knowledge of local 
services. Reviewers were able to seek support and advice from 
other members of the ESD team. However, another potential 
criticism is that the study did not include a third randomiza-
tion group to determine if nonspecialist support and reassur-
ance could have resulted in similar improvements to mood and 
quality of life seen in the EXTRAS intervention group.
Participants in the control group received usual care post-
ESD. Usual care is not standardized and, therefore, the care 
received by participants in the control group will have varied. 
Studies consistently report that patients with stroke receive 
very little longer term rehabilitation.6,28,29
Further research to develop and evaluate community 
services to meet the long-term and ongoing needs of stroke 
survivors, and carers is needed. In particular, longer term 
interventions to improve performance in extended activities 
of daily living. It will also be important to understand the 
mechanisms by which quality of life is improved, and costs 
are reduced by provision of preplanned intermittent longer 
term specialist review.
Conclusions
EXTRAS did not significantly improve stroke survivors’ 
performance in extended activities of daily living. However, 
given the impact upon costs and QALYS, EXTRAS may be 
an affordable approach to providing ongoing specialist stroke 
care beyond ESD.
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